Isabel Teresa Rubio

13PUBLICATIONS
80CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological modellingConflict of laws (incl. private international law)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jan 21, 2026
Marking Techniques for Target Lymph Nodes in Node-Positive Breast Cancer Treated With Neoadjuvant Therapy in the AXSANA/EUBREAST-03/AGO-B-053 Study.

Maggie Banys-Paluchowski, Steffi Hartmann, Jana de Boniface

|Sep 18, 2025
Axillary dissection for low-volume nodal involvement after neoadjuvant therapy in breast cancer: multicentre AXSANA cohort study.

Thorsten Kühn, Maggie Banys-Paluchowski, Nina Ditsch

|Jun 04, 2025
Accuracy and Reproducibility of ChatGPT Responses to Breast Cancer Tumor Board Patients.

|Dec 19, 2024
Risk-based breast cancer screening: What are the challenges?

Isabel T Rubio, Caroline A Drukker, Antonio Esgueva

|May 13, 2024
Joint EANM-SNMMI guideline on the role of 2-[18F]FDG PET/CT in no special type breast cancer : (endorsed by the ACR, ESSO, ESTRO, EUSOBI/ESR, and EUSOMA).

Sofia C Vaz, John Patrick Pilkington Woll, Fatima Cardoso

|Jan 19, 2024
Locoregional Breast Cancer Recurrence in the European Organisation for Research and Treatment of Cancer 10041/BIG 03-04 MINDACT Trial: Analysis of Risk Factors Including the 70-Gene Signature.

Sena Alaeikhanehshir, Taiwo Ajayi, Frederieke H Duijnhoven

Pageof 3

Frequent Collaborators

4 joint publications

Oreste Davide Gentilini

4 joint publications

Thorsten Kühn

4 joint publications

Jana de Boniface

3 joint publications

Laura Niinikoski